GlassScriptPhysician profile
Flora Loomis
NPI 1598534760
$1,436.13
in general payments reported to CMS, 2019-2025
18 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $62.07 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.91 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $338.94 | 2025 | Vafseo |
| Mallinckrodt Hospital Products INC. | $287.31 | 2025 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $187.23 | 2025 | |
| Calliditas Therapeutics US INC. | $172.48 | 2025 | Tarpeyo |
| Scpharmaceuticals INC. | $67.44 | 2025 | |
| Novartis Pharmaceuticals Corporation | $60.01 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $59.82 | 2025 | Jynarque, Voyxact |
| Apellis Pharmaceuticals, INC. | $38.32 | 2025 | Empaveli |
| Amgen INC. | $36.01 | 2025 | Tavneos |
| Pfizer INC. | $34.21 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $23.56 | 2025 | Farxiga |
| Aurinia Pharma U.S., INC. | $23.04 | 2025 | Lupkynis |
| Ardelyx, INC. | $22.69 | 2025 | Ibsrela |
| Opko Pharmaceuticals, LLC | $21.73 | 2025 | Rayaldee |
| Lilly USA, LLC | $20.05 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $15.43 | 2025 | |
| Esperion Therapeutics, INC. | $13.94 | 2024 | Nexletol |
| Abbvie INC. | $13.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Flora Loomis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.